LUPIN - RECEIVES U.S. FDA APPROVAL FOR DAPAGLIFLOZIN AND METFORMIN XR TABLETS
LUPIN ANNOUNCES APPROVAL OF DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS IN THE UNITED STATES
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.